Keyphrases
Latin American
100%
Lupus
100%
Patient Data
100%
Multi-ethnic
100%
Renal Damage
100%
Systemic Lupus Erythematous
100%
Lupus Nephritis
66%
Proteinuria
55%
Hypertension
33%
Antimalarial Use
33%
Early Response
33%
Risk Factors
22%
Male Gender
22%
SLE Disease Activity Index (SLEDAI)
22%
Renal Activity
22%
Red Cells
11%
Selection Strategy
11%
Prednisone
11%
Response to Treatment
11%
Drug Use
11%
Cox Regression Model
11%
Systemic Lupus Erythematosus Patient
11%
Damage Index
11%
Immunosuppressive Drugs
11%
Systemic Lupus International Collaborating Clinics
11%
American College of Rheumatology
11%
Backward Selection
11%
Creatinine Level
11%
Anti-double-stranded DNA Antibodies
11%
Low Complement
11%
Medicine and Dentistry
Systemic Lupus Erythematosus
100%
Lupus Erythematosus
100%
Kidney Injury
100%
Patient-Data
100%
Lupus Nephritis
66%
Proteinuria
55%
Antimalarial Agent
33%
SLEDAI
22%
Proportional Hazards Model
11%
Prednisone
11%
Rheumatology
11%
Immunosuppressive Drug
11%
Creatinine
11%
Double Stranded DNA Antibody
11%
Renovascular Hypertension
11%